GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $24,000 | -4.0% | 534 | -2.9% | 0.01% | +11.1% |
| Q4 2021 | $25,000 | +19.0% | 550 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $21,000 | -8.7% | 550 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $23,000 | +228.6% | 550 | +175.0% | 0.01% | +200.0% |
| Q1 2021 | $7,000 | -53.3% | 200 | -51.0% | 0.00% | -62.5% |
| Q4 2020 | $15,000 | 0.0% | 408 | -1.7% | 0.01% | 0.0% |
| Q3 2020 | $15,000 | +15.4% | 415 | +30.5% | 0.01% | 0.0% |
| Q2 2020 | $13,000 | 0.0% | 318 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $13,000 | +85.7% | 318 | +122.4% | 0.01% | +80.0% |
| Q4 2019 | $7,000 | +133.3% | 143 | +138.3% | 0.01% | +150.0% |
| Q1 2019 | $3,000 | +50.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $2,000 | -81.8% | 60 | -76.6% | 0.00% | -85.7% |
| Q2 2018 | $11,000 | +10.0% | 256 | -0.8% | 0.01% | 0.0% |
| Q1 2018 | $10,000 | +11.1% | 258 | -1.1% | 0.01% | 0.0% |
| Q4 2017 | $9,000 | – | 261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |